课题基金 / 基金详情

EAGER: Demonstrating the Physics of Novel Solution-Phase Electrochemical Aptamer Sensors

EAGER: Demonstrating the Physics of Novel Solution-Phase Electrochemical Aptamer Sensors
EAGER:展示新型溶液相电化学适体传感器的物理原理
批准号:
2125056
负责人:
Jason Heikenfeld
金额:
$25.1万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2023-12-31

项目摘要

项目成果

Jason Heikenfeld的其他基金

相似基金

相关文献

中文摘要
翻译
糖尿病的连续葡萄糖监测是现代诊断学的一项历史性成就,但不幸的是,尽管在更广泛的人类医学领域有许多迫切的需求,但这只是一个孤立的成功。 葡萄糖监测仍然是一个孤立的成功,因为葡萄糖传感器是基于酶,这可能是具有挑战性的开发分析物以外的代谢物(如葡萄糖,乳酸盐,乙醇)。 另一类称为电化学适体传感器的传感器更容易开发用于葡萄糖以外的分析物(激素,药物,蛋白质),但适体传感器尚未证明大多数医疗应用所需的使用寿命,并且通常在其灵敏度方面存在限制。 这些寿命和灵敏度挑战至少部分地存在,因为必须在电极表面上组装并保留完美的适体层。 该项目将展示和探索基于溶液相电化学适体传感器的新传感器方法的物理学。简单地说,允许适体在溶液中自由漂浮,并且当分析物与适体结合时,适体以可通过电极测量的方式改变形状。 溶液相电化学适体传感器将在以下方面提供显著的优点:(1)由于其简单性而具有突破性的寿命和鲁棒性,以及(2)由于其高度可调的物理特性而具有改进的灵敏度。 该项目与实现个性化医疗的目标一致,通过创建一种新的生物传感器方法,允许对人类健康和医学领域的激素、肽、治疗药物和其他标记物进行连续生物传感。在初步工作的基础上,该项目追求两个具体目标。 目的1 -使用为光学测量的适体开发的现有适体设计来证明溶液相电化学适体传感器的基本物理。追求这一目标的理由是,充分利用充分表征和建模的适体将允许在这个项目中的新的实验数据的快速理论理解。 该目标的产物将是至少一种适体,然后可以在目标2中重新设计。 目的2 -创建用于修改适体设计以实现电化学信号的最大变化的基本原理工具集。 通过在追求特定应用工作之前展示这种基本设计工具集,第二个目标将使所有研究人员能够更快地推进溶液相电化学适体传感器的新领域。 这一目标的产物将是溶液相电化学适体传感器物理学的新知识,还有一个跟踪的发射台在基础和应用方面的工作,以创造可佩戴在身体上或植入体内的连续生物传感器。该奖项反映了NSF的法定使命,并被认为值得通过使用基金会的智力价值和更广泛的影响审查进行评估来支持的搜索.
英文摘要
Continuous glucose monitoring for diabetes is a historical achievement in modern diagnostics, but unfortunately is an isolated success despite numerous acute needs across the broader field of human medicine. Glucose monitoring remains an isolated success because glucose sensors are based on enzymes which can be challenging to develop for analytes other than metabolites (e.g. glucose, lactate, ethanol). An alternate class of sensors called electrochemical aptamer sensors are simpler to develop for analytes beyond glucose (hormones, drugs, proteins), but aptamer sensors have not yet demonstrated the longevity of use required for most medical applications and often have limits in their sensitivity. These longevity and sensitivity challenges, at least in part, exist because a perfect layer of aptamer must be assembled and retained on an electrode surface. This project will demonstrate and explore the physics of a new sensor approach based on solution-phase electrochemical aptamer sensors. Simply, the aptamers are allowed to float freely in solution, and when an analyte binds with an aptamer the aptamer changes in shape in a way that is measurable by an electrode. Solution-phase electrochemical aptamer sensors will provide significant advantages in terms of (1) breakthrough longevity and robustness due to their simplicity, and (2) improved sensitivity due to their highly tunable physics. This project aligns with the goal of enabling personalized medicine, by creating a new approach for biosensors that allow continuous biosensing of hormones, peptides, therapeutic drugs, and other markers across human health and medicine. Building upon preliminary work, this project pursues two specific aims. Aim 1 - demonstrate the underlying physics of solution-phase electrochemical aptamer sensors using existing aptamer designs developed for optically measured aptamers. The rationale for pursuing this aim is that leveraging fully characterized and modeled aptamers will allow a rapid theoretical understanding of new experimental data in this project. The product of this aim will be at least one aptamer that can then be redesigned in Aim 2. Aim 2 - create a rationale toolset for modifying aptamer design for achieving maximum changes in electrochemical signal. By demonstrating this fundamental design toolset before pursuing application-specific work, this second aim will enable all researchers to more rapidly advance a new field of solution-phase electrochemical aptamer sensors. The product of this aim will be both new knowledge of the physics of solution-phase electrochemical aptamer sensors, and a launch-pad for follow-on work in both fundamental and applied proposals to create continuous biosensors that can be worn on the body or implanted in the body.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41551-022-00998-9
发表时间: 2023-01-19
期刊: NATURE BIOMEDICAL ENGINEERING
影响因子: 28.1
作者: [Friedel, Mark, Thompson, Ian A. P., Heikenfeld, Jason]
通讯作者: Heikenfeld, Jason
Solution-Phase Electrochemical Aptamer-Based Sensors
基于溶液相电化学适体的传感器
DOI: 10.1109/tbme.2022.3203026
发表时间: 2023
期刊: IEEE Transactions on Biomedical Engineering
影响因子: 4.6
作者: [Yuan, Yuchan, Bali, Ahilya, White, Ryan J., Heikenfeld, Jason]
通讯作者: Heikenfeld, Jason
An Implantable Biosensor Platform Enabled by Novel Porous Oxide Protection of Electrochemical Aptamer Working Electrodes
  • 批准号:
    2327102
  • 项目类别:
    Standard Grant
  • 资助金额:
    $45.0万
  • 财政年份:
    2023
  • 负责人:
    Jason Heikenfeld
  • 依托单位:
Collaborative Research: Rapid Biosensing of Protein-Bound Drug Concentrations in the Body for Improved Drug Efficacy and Safety
  • 批准号:
    2025720
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $30.76万
  • 财政年份:
    2020
  • 负责人:
    Jason Heikenfeld
  • 依托单位:
Chronologically Correlated Sweat Biosensing
  • 批准号:
    1608275
  • 项目类别:
    Standard Grant
  • 资助金额:
    $37.5万
  • 财政年份:
    2016
  • 负责人:
    Jason Heikenfeld
  • 依托单位:
EAGER: Sweat, Sense, and Signal (S3) ? Demonstration of fM to pM Electrical Sensing of BioMarkers in Sweat
  • 批准号:
    1347725
  • 项目类别:
    Standard Grant
  • 资助金额:
    $16.0万
  • 财政年份:
    2013
  • 负责人:
    Jason Heikenfeld
  • 依托单位:
海外基金